227 related articles for article (PubMed ID: 28112515)
61. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
[TBL] [Abstract][Full Text] [Related]
62. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
[TBL] [Abstract][Full Text] [Related]
63. Trypanosome glucose transporters.
Barrett MP; Tetaud E; Seyfang A; Bringaud F; Baltz T
Mol Biochem Parasitol; 1998 Mar; 91(1):195-205. PubMed ID: 9574935
[No Abstract] [Full Text] [Related]
64. Trypanosoma brucei: trypanocidal and cell swelling activities of lasalocid acid.
Steverding D; Huczyński A
Parasitol Res; 2017 Nov; 116(11):3229-3233. PubMed ID: 28956164
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes.
Taladriz A; Healy A; Flores Pérez EJ; Herrero García V; Ríos Martínez C; Alkhaldi AA; Eze AA; Kaiser M; de Koning HP; Chana A; Dardonville C
J Med Chem; 2012 Mar; 55(6):2606-22. PubMed ID: 22390399
[TBL] [Abstract][Full Text] [Related]
66. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
Loiseau PM; Wolf JG; Gayral P
Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
[TBL] [Abstract][Full Text] [Related]
67. Singly and doubly modified analogues of C20-epi-salinomycin: A new group of antiparasitic agents against Trypanosoma brucei.
Czerwonka D; Barcelos Y; Steverding D; Cioch A; Huczyński A; Antoszczak M
Eur J Med Chem; 2021 Jan; 209():112900. PubMed ID: 33071053
[TBL] [Abstract][Full Text] [Related]
68. Trypanosome alternative oxidase: from molecule to function.
Chaudhuri M; Ott RD; Hill GC
Trends Parasitol; 2006 Oct; 22(10):484-91. PubMed ID: 16920028
[TBL] [Abstract][Full Text] [Related]
69. Novel distamycin analogues that block the cell cycle of African trypanosomes with high selectivity and potency.
Franco J; Scarone L; Comini MA
Eur J Med Chem; 2020 Mar; 189():112043. PubMed ID: 31978782
[TBL] [Abstract][Full Text] [Related]
70. Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs.
Giordani F; Paape D; Vincent IM; Pountain AW; Fernández-Cortés F; Rico E; Zhang N; Morrison LJ; Freund Y; Witty MJ; Peter R; Edwards DY; Wilkes JM; van der Hooft JJJ; Regnault C; Read KD; Horn D; Field MC; Barrett MP
PLoS Pathog; 2020 Nov; 16(11):e1008932. PubMed ID: 33141865
[TBL] [Abstract][Full Text] [Related]
71. Trypanocidal activity of ethanolic extracts of Commiphora swynnertonii Burtt on Trypanosoma congolense.
Nagagi YP; Silayo RS; Kweka EJ
BMC Complement Altern Med; 2016 Jul; 16():195. PubMed ID: 27392030
[TBL] [Abstract][Full Text] [Related]
72. Bistacrines as potential antitrypanosomal agents.
Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
[TBL] [Abstract][Full Text] [Related]
73. Diamine and aminoalcohol derivatives active against Trypanosoma brucei.
Olmo ED; Diaz-González R; Escarcena R; Carvalho L; Bustos LA; Navarro M; Feliciano AS
Bioorg Med Chem Lett; 2012 Jan; 22(1):440-3. PubMed ID: 22119463
[TBL] [Abstract][Full Text] [Related]
74. Differences in Transporters Rather than Drug Targets Are the Principal Determinants of the Different Innate Sensitivities of
Ungogo MA; Campagnaro GD; Alghamdi AH; Natto MJ; de Koning HP
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269985
[TBL] [Abstract][Full Text] [Related]
75. An evaluation of Minor Groove Binders as anti-Trypanosoma brucei brucei therapeutics.
Scott FJ; Khalaf AI; Giordani F; Wong PE; Duffy S; Barrett M; Avery VM; Suckling CJ
Eur J Med Chem; 2016 Jun; 116():116-125. PubMed ID: 27060763
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT).
Carrillo AK; Guiguemde WA; Guy RK
Bioorg Med Chem; 2015 Aug; 23(16):5151-5. PubMed ID: 25637120
[TBL] [Abstract][Full Text] [Related]
77. Cattle breeding, trypanosomosis prevalence and drug resistance in Northern Togo.
Tchamdja E; Kulo AE; Vitouley HS; Batawui K; Bankolé AA; Adomefa K; Cecchi G; Hoppenheit A; Clausen PH; De Deken R; Van Den Abbeele J; Marcotty T; Delespaux V
Vet Parasitol; 2017 Mar; 236():86-92. PubMed ID: 28288771
[TBL] [Abstract][Full Text] [Related]
78. The biochemistry of African trypanosomes and its significance for chemotherapy.
Braide VB
J Vet Pharmacol Ther; 1987 Sep; 10(3):191-201. PubMed ID: 3309362
[No Abstract] [Full Text] [Related]
79. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
[TBL] [Abstract][Full Text] [Related]
80. Functional and structural analysis of AT-specific minor groove binders that disrupt DNA-protein interactions and cause disintegration of the Trypanosoma brucei kinetoplast.
Millan CR; Acosta-Reyes FJ; Lagartera L; Ebiloma GU; Lemgruber L; Nué Martínez JJ; Saperas N; Dardonville C; de Koning HP; Campos JL
Nucleic Acids Res; 2017 Aug; 45(14):8378-8391. PubMed ID: 28637278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
